Chemotherapy-Induced Nausea and Vomiting (CINV) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChemotherapy-Induced Nausea and Vomiting (CINV) Market?
The rise in cancer cases is anticipated to spur the development of the chemotherapy-induced nausea and vomiting (CINV) market. Uncontrolled cell growth and spreading across the body is the essence of cancer. As cancer incidence increases, there is a heightened drive towards the creation of more proficient, specialized anti-emetic treatments to mitigate CINV, an uncomfortable chemotherapy complication. This emphasis on managing CINV has resulted in strides in comprehending its basic processes and initiating new therapies. For example, the American Cancer Society (ACS), a US-based volunteer health organization committed to eradicating cancer, predicted approximately 5,370 new cancer cases per day (totalling to 1.9 million annually) and around 1,670 cancer-related deaths daily (totalling to 609,820 annually) in the United States in 2023. Hence, the rising cancer prevalence is a primary driver for the CINV market’s growth.
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Driver: Positive Regulatory Initiatives Propel the Growth of the CINV Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13031&type=smp
#What is the Projected CAGR for the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size from 2025 to 2034?
The market for Chemotherapy-Induced Nausea and Vomiting (CINV) has seen robust growth in recent times. It is projected to expand from a market size of $2.92 billion in 2024 to reach $3.15 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.9%. Factors such as the increased use of chemotherapy, enhancements in antiemetic agents, the establishment of clinical guidelines, and patient advocacy have all contributed to the upward trajectory during the past period.
Expectations predict robust expansion in the chemotherapy-induced nausea and vomiting (CINV) market size in the up-coming years. Projected to ascend to a value of $4.2 billion in 2029, its compound annual growth rate (CAGR) is estimated at 7.5%. Factors leading to advancement during the forecast period include personalized treatments, improvements in antiemetic medications, telehealth, remote monitoring programs, and health equity drives. The period’s principal trends constitute combined antiemetic treatment methods, supplemental care services, digital healthcare devices, and survivorship care.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13031
What Are the Current Market Growth and Trends in theChemotherapy-Induced Nausea and Vomiting (CINV) Market That Industry Players Should Watch?
Major companies operating in the chemotherapy-induced nausea and vomiting (CINV) market are working on new product innovations, such as fixed intravenous antiemetic, to gain a competitive advantage. A fixed intravenous antiemetic refers to a predetermined dose of medication administered through an IV to prevent or treat nausea and vomiting, commonly used in chemotherapy or post-surgery settings. For instance, in January 2023, Glenmark Pharmaceuticals Limited, an India-based manufacturer of pharmaceuticals, generics, and over-the-counter (OTC) products, introduced AKYNZEO I.V. in India, the first fixed intravenous antiemetic combination designed to prevent chemotherapy-induced nausea and vomiting (CINV). The product combines netupitant and palonosetron, targeting both acute and delayed phases of nausea and vomiting. It offers single-dose convenience, improved complete response rates, and enhanced quality of life for cancer patients. Clinical studies show it is particularly beneficial for highly emetogenic chemotherapy patients.
What Are the Major Market Players Making an Impact on theChemotherapy-Induced Nausea and Vomiting (CINV) Market Growth?
Major companies operating in the chemotherapy-induced nausea and vomiting (cinv) market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC, Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., Soligenix Inc.
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Driving Opportunities and Innovations?
The chemotherapy-induced nausea and vomiting (CINV) market covered in this report is segmented –
1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications
Subsegments:
1) By Injectables: Intravenous (IV) Solutions, Intramuscular (IM) Injections
2) By Oral: Tablets, Capsules, Liquid Formulations
3) By Transdermal Patches: Fentanyl Patches, Scopolamine Patches
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13031&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChemotherapy-Induced Nausea and Vomiting (CINV) Market?# Market Expansion?
North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2024. The regions covered in chemotherapy-induced nausea and vomiting (CINV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market 2025, By The Business Research Company:
High Performance Liquid Chromatography Global Market Report 2024
High Performance Liquid Chromatography Global Market Report 2024
Gas Chromatography Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gas-chromatography-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
